WO2010082212A3 - N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses - Google Patents
N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses Download PDFInfo
- Publication number
- WO2010082212A3 WO2010082212A3 PCT/IN2009/000351 IN2009000351W WO2010082212A3 WO 2010082212 A3 WO2010082212 A3 WO 2010082212A3 IN 2009000351 W IN2009000351 W IN 2009000351W WO 2010082212 A3 WO2010082212 A3 WO 2010082212A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- alkyl
- linear
- branched alkyl
- chemical bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
N- Biphenylacyl — thiazolidine-2,4-dione derivatives of the general formula (I); where in, Z1 and Z2 represent H, or together forms a chemical bond; R1 represents H, alkoxy, nitro, halo, hydroxy, optionally substituted amino group, - O-(CH2)n-N(R7)(R8), -O-(CH2)n-R9, wherein n is 0 to 5, -COOH, -CN, linear or branched alkyl, substituted alkyl, cycloalkyl, -S-R11 alkyl thio, acyl, aroyl, substituted or unsubstituted heterocyclic, alkoxy carbonyl, aryloxy, aryloxy carbonyl; R2 represents H, halo, hydroxy, linear or branched alkyl, substituted alkyl; R3, R4, R5 independently represents H, alkoxy, hydroxy, linear or branched alkyl, substituted alkyl; R6 represents H, -COOH, linear or branched alkyl, -CN, -SO3H, optionally substituted amino group; R7 represents H, linear or branched alkyl, cyclo alkyl, acyl, aroyl, aralkyl where in aryl moiety is substituted or unsubstituted, or an aryl; R8 represents a substituted or unsubstituted heterocyclic, linear or branched alkyl, substituted alkyl; R9 represents a substituted or unsubstituted heterocyclic, substituted or unsubstituted aromatic, substituted or unsubstituted cycloalkyl, fused arylheterocyclyl; when R1 represents alkoxy group, and Z1 and Z2 together forms a chemical bond then, R2 or R3 or R4 or R5 is other than H, and when R1, R2, R3, R4, R5 are each independently represents H, and Z1 and Z2 together forms a chemical bond then R6 is not H; And when R1, R2, R3, R4, R5 represents independently or together halo group and - Z1 and Z2 together forms a chemical bond, then R6 is not H; are novel compounds, their isomers and their enantiomers and their pharmaceutically acceptable salts or solvates and their pharmaceutical compositions containing such compounds and the use of such compounds and compositions in medicines and process for preparing the same.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1299MU2008 | 2008-06-23 | ||
| IN1299/MUM/2008 | 2008-06-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2010082212A2 WO2010082212A2 (en) | 2010-07-22 |
| WO2010082212A3 true WO2010082212A3 (en) | 2011-01-27 |
Family
ID=42340172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2009/000351 Ceased WO2010082212A2 (en) | 2008-06-23 | 2009-06-18 | N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2010082212A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012041253A1 (en) * | 2010-09-30 | 2012-04-05 | Zhejiang Beta Pharma Inc. | Compounds for increase of hdl-c level and uses thereof |
| CN104744388A (en) * | 2015-03-03 | 2015-07-01 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing tetrazole structure, preparation method of PTP1B inhibitor and use of PTP1B inhibitor |
| CN104744387A (en) * | 2015-03-03 | 2015-07-01 | 佛山市赛维斯医药科技有限公司 | PTP1B inhibitor containing tetrazole and halobenzene structures, preparation method of PTP1B inhibitor and use of PTP1B inhibitor |
| CN105315223B (en) * | 2015-11-06 | 2017-08-25 | 河南大学 | A kind of high three-dimensional and high enantioselectivity thiazolidine dione compounds, its preparation method and application |
| WO2019016826A1 (en) * | 2017-07-17 | 2019-01-24 | Guru Ghasidas Vishwavidyalaya (A Central University) | Novel 5-[4-(2-biphenyl-4-yl-2-oxo-ethoxy)-benzylidene]-thiazolidine-2,4-diones, their synthesis and uses thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005026127A1 (en) * | 2003-09-11 | 2005-03-24 | Institute Of Medicinal Molecular Design. Inc. | Plasminogen activator inhibitor-1 inhibitor |
| BRPI0601826A (en) * | 2006-03-24 | 2007-11-27 | Univ Fed Pernambuco | thiazolidinedinic compounds with hypoglycemic activity |
-
2009
- 2009-06-18 WO PCT/IN2009/000351 patent/WO2010082212A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005026127A1 (en) * | 2003-09-11 | 2005-03-24 | Institute Of Medicinal Molecular Design. Inc. | Plasminogen activator inhibitor-1 inhibitor |
| BRPI0601826A (en) * | 2006-03-24 | 2007-11-27 | Univ Fed Pernambuco | thiazolidinedinic compounds with hypoglycemic activity |
Non-Patent Citations (4)
| Title |
|---|
| ANNALES PHARMACEUTIQUES FRANCAISES, vol. 51, no. 6, 1993, pages 283 - 291 * |
| DATABASE CAPLUS DE LIMA, J. G. ET AL.: "Quantitative structure-hypoglycemic activity relation of some substituted thiazolidine- and imidazolidine-2,4- diones", Database accession no. 1994:152973 * |
| DATABASE CAPLUS GILDO DE LIMA, JOSE ET AL.: "Electron impact mass spectra of 3- phenacyl-5-benzylidenethiazolidine-2,4-dione and -imidazolidine- 2,4-dione compounds", accession no. STN Database accession no. 1994:243873 * |
| SPECTROSCOPY, vol. 11, no. 1-6, 1993, pages 45 - 53 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010082212A2 (en) | 2010-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161559A0 (en) | Dibenzylamine derivatives and pharmaceutical compositions containing the same | |
| WO2008010048A3 (en) | Novel 2-substituted methyl penam derivatives | |
| WO2005095409A3 (en) | Tetrahydroquinoline derivatives and a process for preparing the same | |
| ATE73797T1 (en) | HETEROCYCLICALLY SUBSTITUTED INDOLES, INTERMEDIATE PRODUCTS, PROCESSES FOR THEIR MANUFACTURE AND PHARMACEUTICALS. | |
| WO2008115098A3 (en) | Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof | |
| MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
| WO2008081096A3 (en) | Quinolinyl derivatives, method for preparing same, pharmaceutic compositions containing same, and use thereof as hypoglycemiant and hypolipemiant agents | |
| MY141245A (en) | Macrocylic inhibitors of hepatitis c virus | |
| MY139887A (en) | Tetrahydronaphthyridine derivatives and a process for preparing the same. | |
| NO20076006L (en) | acetylene Derivatives | |
| MX2009003927A (en) | Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes. | |
| WO2010033643A3 (en) | Small molecule compounds for stem cell differentiation | |
| WO2021008588A9 (en) | Class of pyrimidine quinoline derivatives and preparation method therefor and application thereof | |
| WO2010082212A3 (en) | N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses | |
| IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| IN2012DN00770A (en) | ||
| WO2006071471A3 (en) | 2-(2 or 4-substituted aryloxy)-phenol derivatives as antibacterial agents | |
| WO2008049997A3 (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| WO2010139967A8 (en) | Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors | |
| WO2009019721A3 (en) | Quercetin derivatives as anti-cancer agents | |
| WO2002083649A1 (en) | Novel imidazolidinedione derivatives and use thereof as drugs | |
| ATE165362T1 (en) | NEW DERIVATIVES OF 2-(1H)-QUINOLINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM | |
| WO2008120661A1 (en) | Novel fused pyrrole derivative | |
| MY139011A (en) | Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| WO2004024735A3 (en) | A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09838192 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 09838192 Country of ref document: EP Kind code of ref document: A2 |